(Q33838684)

29 July 2017

1 reference

title

Amiodarone: what have we learned from clinical trials? (English)

1 reference

29 July 2017

1 reference

G V Naccarelli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655150&resulttype=core&format=json

15 May 2020

D L Wolbrette

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655150&resulttype=core&format=json

15 May 2020

J T Dell'Orfano

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655150&resulttype=core&format=json

15 May 2020

H M Patel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655150&resulttype=core&format=json

15 May 2020

J C Luck

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655150&resulttype=core&format=json

15 May 2020

language of work or name

1 reference

1 February 2000

1 reference

29 July 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655150&resulttype=core&format=json

15 May 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655150&resulttype=core&format=json

15 May 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655150&resulttype=core&format=json

15 May 2020

page(s)

73-82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655150&resulttype=core&format=json

Predicting and preventing sudden death from cardiac causes

15 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960230203

Beta-blockers and sudden cardiac death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960230203

Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960230203

Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Dep

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960230203

Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960230203

Design and results of the antiarrhythmics vs implantable defibrillators (AVID) registry. The AVID Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960230203

Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960230203

Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960230203

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction

21 January 2018

1 reference

12 December 2020

Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study

1 reference

12 December 2020

Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators

1 reference

12 December 2020

Cumulative meta-analysis of therapeutic trials for myocardial infarction

1 reference

12 December 2020

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

1 reference

12 December 2020

Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy

1 reference

12 December 2020

Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS)

1 reference

12 December 2020

Mortality in heart failure: clinical variables of prognostic value

1 reference

12 December 2020

Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure

1 reference

12 December 2020

Amiodarone: risk factors for recurrence of symptomatic ventricular tachycardia identified at electrophysiologic study

1 reference

12 December 2020

Controlled trial of sotalol for one year after myocardial infarction

1 reference

12 December 2020

International mexiletine and placebo antiarrhythmic coronary trial: I. Report on arrhythmia and other findings. Impact Research Group

1 reference

12 December 2020

The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction

1 reference

12 December 2020

Comparison of the effects of amiodarone versus metoprolol on the frequency of ventricular arrhythmias and on mortality after acute myocardial infarction. SSSD Investigators. Spanish Study on Sudden Death

1 reference

12 December 2020

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

1 reference

12 December 2020

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

1 reference

12 December 2020

Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA).

1 reference

12 December 2020

Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

1 reference

12 December 2020

Prevention of sudden death in patients with coronary artery disease: the Multicenter Unsustained Tachycardia Trial (MUSTT)

1 reference

12 December 2020

Canadian Implantable Defibrillator Study (CIDS): study design and organization. CIDS Co-Investigators.

1 reference

12 December 2020

Preliminary results of the Cardiac Arrest Study Hamburg (CASH). CASH Investigators

1 reference

12 December 2020

Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators

1 reference

12 December 2020

Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials

1 reference

12 December 2020

The epidemiology of heart failure: the Framingham Study

1 reference

12 December 2020

Long-term benefit of 1-year amiodarone treatment for persistent complex ventricular arrhythmias after myocardial infarction

1 reference

12 December 2020

Nonsustained ventricular tachycardia in coronary artery disease: relation to inducible sustained ventricular tachycardia. MUSTT Investigators

1 reference

12 December 2020

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.

1 reference

12 December 2020

ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)

1 reference

12 December 2020

Improving survival for patients with atrial fibrillation and advanced heart failure

1 reference

12 December 2020

Adjunctive drug therapy of acute myocardial infarction--evidence from clinical trials

1 reference

12 December 2020

Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators

1 reference

12 December 2020

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators

1 reference

12 December 2020

Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators

1 reference

12 December 2020

Heart rate is a marker of amiodarone mortality reduction in severe heart failure. The GESICA-GEMA Investigators. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina-Grupo de Estudios Multicéntricos en Argentina

1 reference

12 December 2020

Influence of patient characteristics in the selection of patients for defibrillator implantation (the AVID Registry). Antiarrhythmics Versus Implantable Defibrillators.

1 reference

12 December 2020

Comparison of clinical characteristics and frequency of implantable defibrillator use between randomized patients in the Antiarrhythmics Vs Implantable Defibrillators (AVID) trial and nonrandomized registry patients

1 reference

12 December 2020

Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators

1 reference

12 December 2020

Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators

1 reference

12 December 2020

Quantitative overview of randomized trials of amiodarone to prevent sudden cardiac death

1 reference

12 December 2020

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

1 reference

12 December 2020

The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial

1 reference

12 December 2020

ICD trials: an extraordinary means of determining patient risk?

1 reference

12 December 2020

A decade of clinical trial developments in postmyocardial infarction, congestive heart failure, and sustained ventricular tachyarrhythmia patients: from CAST to AVID and beyond. Cardiac Arrhythmic Suppression Trial. Antiarrhythmic Versus Implantable

1 reference

12 December 2020

Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. Department of Veterans Affairs CHF STAT Investigators

1 reference

12 December 2020

Identifiers

DOI

10.1002/CLC.4960230203

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655150&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655150&resulttype=core&format=json

15 May 2020

10676597

1 reference